A tan in a test tube -in vitro models for investigating ultraviolet radiation-induced damage in skin

Experimental Dermatology

Volumn 21, Issue 6, 2012, Pages 404-410

  Fernandez, Tara L ^a   Dawson, Rebecca A ^a   Van Lonkhuyzen, Derek R ^a   Kimlin, Michael G ^a   Upton, Zee ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Animal models; Cell culture; Human skin equivalents; Melanoma; Skin cancer in vitro models; Tissue engineered models; Ultraviolet radiation

Indexed keywords

C57BL 6 MOUSE; CARCINOGENESIS; CD1 MOUSE; CELL CULTURE; DDB2 MOUSE; DISEASE MODEL; EXPERIMENTAL MOUSE; EXPLANT; FVB N MOUSE; GOAT; HGF SF MOUSE; HORSE; HUMAN; HUPKI MOUSE; IN VITRO STUDY; K5.CRE PR1 MOUSE; MC1R MOUSE; MOUSE STRAIN; NEO P53 MOUSE; NONHUMAN; OPOSSUM; PHOTOBIOLOGY; PTCH1 MOUSE; RADIATION INJURY; REVIEW; SENSITIVE TO CARCINOGENESIS MOUSE; SKIN CANCER; SKIN INJURY; TG AC MOUSE; TISSUE ENGINEERING; TYR SV40E MOUSE; ULTRAVIOLET RADIATION; VDR MOUSE; XPA TRP53 MOUSE; XPC MOUSE; ZEBRA FISH;

ANIMALS; CELL CULTURE TECHNIQUES; HUMANS; MODELS, ANIMAL; ORGAN CULTURE TECHNIQUES; SKIN; TISSUE ENGINEERING; ULTRAVIOLET RAYS;

EID: 84861479691     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01485.x     Document Type: Review

References (143)

1. Richmond-Sinclair N M, Pandeya N, Williams G M et al. Int J Cancer 2009: 129: 323-328.
2. Matsumura Y, Ananthaswamy H N. Front Biosci 2002: 7: d765-d783.
3. Slominski A, Wortsman J. Endocr Rev 2000: 21: 457-487.
4. Nylander K, Bourdon J C, Bray S E et al.J Pathol 2000: 190: 39-46.
5. Chuong C M, Nickoloff B J, Elias P M et al. Exp Dermatol 2002: 11: 159-187.
6. Slominski A, Wortsman J, Paus R et al. Drug Discov Today Dis Mech 2008: 5: 137-144.
7. Slominski A, Wortsman J, Tuckey R C et al. Mol Cell Endocrinol 2007: 266: 143-149.
8. Slominski A, Wortsman J, Pisarchik A et al. Faseb J 2001: 15: 1678-1693.
9. Slominski A, Wortsman J, Luger T et al. Physiol Rev 2000: 80: 979-1020.
10. Slominski A, Baker J, Ermak G et al. FEBS Lett 1996: 399: 175-176.
11. Quevedo M E, Slominski A, Pinto W et al. In Vitro Cell Dev Biol Anim 2001: 37: 50-54.
12. Zbytek B, Slominski A T. J Cell Physiol 2005: 203: 118-126.
13. Dong L, Wen J, Pier E et al. Cancer Res 2010: 70: 3547-3556.
14. Ito N, Ito T, Kromminga A et al. FASEB J 2005: 19: 1332-1334.
15. Slominski A, Mihm M C. Int J Dermatol 1996: 35: 849-851.
16. Slominski A. Exp Dermatol 2009: 18: 760-763.
17. Slominski A, Pisarchik A, Semak I et al. FASEB J 2002: 16: 896-898.
18. Kosztka L, Rusznák Z, Nagy D et al. Melanoma Res 2011: 21: 308-322.
19. Wood J, Pring M, Eveson J W et al. Br J Cancer 2011: 104: 1459-1471.
20. Yang W, Wu Y H, Yin D et al. Technol Cancer Res Treat 2011: 10: 281-286.
21. Yoshihisa Y, Honda A, Zhao Q L et al. Exp Dermatol 2010: 19: 1000-1006.
22. Briske-Anderson M J, Finley J W, Newman S M. Proc Soc Exp Biol Med 1997: 214: 248-257.
23. Chang-Liu C M, Woloschak G E. Cancer Lett 1997: 113: 77-86.
24. Cheng I H, Lin Y C, Hwang E et al. Neuroscience 2011: 183: 178-188.
25. Dawson R A, Goberdhan N J, Freedlander E et al. Burns 1996: 22: 93-100.
26. Lewis D A, Travers J B, Somani A-K et al. Oncogene 2010: 29: 1475-1485.
27. Black H S, deGruijl F R, Forbes P D et al.J Photochem Photobiol, B 1997: 40: 29-47.
28. Stanton M F. J Natl Cancer Inst 1965: 34: 117-130.
29. Fernandez A A, Paniker L, Garcia R et al. Comp Biochem Physiol C Toxicol Pharmacol 2012: 155: 64-70.
30. Geiger G A, Fu W, Kao G D. Cancer Res 2008: 68: 3396-3404.
31. Naruse K, Fukamachi S, Mitani H et al. Genetics 2000: 154: 1773-1784.
32. Schartl M, Wilde B, Laisney J A et al.J Invest Dermatol 2010: 130: 249-258.
33. Ahmed F E, Setlow R B. Cancer Res 1993: 53: 2249-2255.
34. Mitchell D L, Fernandez A A, Nairn R S et al. Proc Natl Acad Sci U S A 2010: 107: 9329-9334.
35. Schwab M, Haas J, Abdo S et al. Experientia 1978: 34: 780-782.
36. Parsons P G, Takahashi H, Candy J et al. Pigment Cell Res 1990: 3: 297-305.
37. Fleury C, Berard F, Balme B et al. Pigment Cell Res 2000: 13: 39-46.
38. Ley R D, Applegate L A, Padilla R S et al. Photochem Photobiol 1989: 50: 1-5.
39. Wang Z, Hubbard G B, Clubb F J et al. Int J Clin Exp Pathol 2009: 2: 286-299.
40. Kusewitt D F, Lewis J L, Griffith W C Jr et al. Radiat Res 1996: 146: 181-191.
41. Sauter E R, Klein-Szanto A J, Atillasoy E et al. Mol Carcinog 1998: 23: 168-174.
42. Halliday G. Mutation Res 2005: 571: 107-120.
43. Kemp C J. Semin Cancer Biol 2005: 15: 460-473.
44. Artandi S E, Chang S, Lee S L et al. Nature 2000: 406: 641-645.
45. Potten C S. Cell Tissue Kinet 1974: 7: 77-88.
46. Heenen M, Thiriar S, Noël J C et al. Dermatol 1998: 197: 123-126.
47. Slominski A, Pawelek J. Clin Dermatol 1998: 16: 503-515.
48. Verkler T L, Delongchamp R R, Couch L H et al. Mol Carcinog 2008: 47: 822-834.
49. Saw C L, Huang M T, Liu Y et al. Mol Carcinog 2011: 50: 479-486.
50. Svobodová A R, Galandáková A, Sianská J et al. Biol Pharm Bull 2011: 34: 471-479.
51. Nandakumar V, Vaid M, Tollefsbol T O et al. Carcinogenesis 2011: 32: 597-604.
52. Mohanan K B, Rozenberg G I, Krishnamurthy J et al. Oncogene 2010: 29: 5809-5817.
53. VanBrocklin M W, Robinson J P, Lastwika K J et al. Pigment Cell Melanoma Res 2010: 23: 531-541.
54. Kimura Y, Sumiyoshi M. Eur J Pharmacol 2011: 661: 124-132.
55. Granholm N H, Van Amerongen A W. J Invest Dermatol 1991: 96: 78-84.
56. Walsh S B, Xu J, Xu H et al. Mol Carcinog 2011: 50: 516-527.
57. Berkin C, Takemoto R, Binder R L et al. Carcinogenesis 2002: 23: 181-187.
58. Ferguson B, Konrad Muller H, Handoko H Y et al. Pigment Cell Melanoma Res 2010: 23: 771-780.
59. Lang G A, Iwakuma T, Suh Y A et al. Cell 2004: 119: 861-872.
60. Barker J H, Hammersen F, Bondàr I et al. Plast Reconstr Surg 1989: 83: 948-959.
61. Walker G J, Kimlin M G, Hacker E et al.J Invest Dermatol 2009: 129: 184-193.
62. Slominski A, Paus R. J Invest Dermatol 1993: 101: 90S-97S.
63. Slominski A, Wortsman J, Plonka P M et al.J Invest Dermatol 2005: 124: 13-21.
64. Hansen L S, Coggle J E, Wells J et al. Anat Rec 1984: 210: 569-573.
65. Slominski A, Paus R, Costantino R. J Invest Dermatol 1991: 96: 172-179.
66. Bikle D D, Chang S, Crumrine D et al.J Invest Dermatol 2004: 122: 984-992.
67. Zinser G M, Welsh J. J Steroid Biochem Mol Biol 2004: 90: 433-436.
68. Takayama H, La Rochelle W J, Anver M et al. Proc Nat Acad Sci USA 1996: 93: 5866-5871.
69. Noonan F P, Otsuka T, Bang S et al. Cancer Res 2000: 60: 3738-3743.
70. Brink N, Szamel M, Young A R et al. Inflamm Res 2000: 49: 290-296.
71. Snellman E, Strozyk M, Segerback D et al. Photodermatol Photoimmunol Photomed 2003: 19: 281-286.
72. Beattie P E, Finlan L E, Kernohan N M et al. Br J Dermatol 2005: 152: 1001-1008.
73. Corre S, Mekideche K, Adamski H et al.J Invest Dermatol 2006: 126: 917-919.
74. Arad S, Konnikov N, Goukassian D A et al.J Invest Dermatol 2007: 127: 2629-2636.
75. Mouret S, Bogdanowicz P, Haure M J et al. Photochem Photobiol 2011: 87: 109-116.
76. Hanson K H, Clegg R M. Photochem Photobiol 2002: 76: 57-63.
77. Reus A A, van Meeuwen R N C, de Vogel N et al. Mutagen 2011: 26: 261-268.
78. Varani J, Perone P, Inman D R et al. Am J Pathol 1995: 146: 210-217.
79. Onuma H, Mastui C, Morohashi M. Arch Dermatol Res 2001: 293: 133-138.
80. Ponec M. Adv Drug Deliv Rev 2002: 54: S19-S30.
81. Valenta C, Auner B G. Biopharmaceutics 2004: 58: 279-289.
82. Yannas I V, Lee E, Orgill D P et al. Proc Natl Acad Sci 1989: 86: 933-937.
83. Ahn S, Yoon H, Kim G et al. Tissue Eng Part C 2010: 16: 813-820.
84. Schafer I A, Shapiro A, Kovach M et al. Exp Cell Res 1989: 183: 112-125.
85. Zhao J F, Zhang Y J, Kubilus J et al. Biochem Biophys Res Commun 1999: 254: 49-53.
86. Poumay Y, Dupont F, Marcoux S et al. Arch Dermatol Res 2004: 296: 203-211.
87. Topping G, Malda J, Dawson R et al. Primary Intention 2006: 14: 14-21.
88. Boelsma E, Gibbs S, Faller C et al. Acta Derm Venereol 2000: 80: 82-88.
89. Amano S, Ogura Y, Akutsu N et al. Br J Dermatol 2005: 153 (Suppl 2): 37-46.
90. Monteiro-Riviere N A, Inman A O, Snider T H et al. Microsc Res Tech 1997: 37: 172-179.
91. Xie Y, Rizzi S C, Dawson R et al. Tissue Eng Part C 2010: 16: 1111-1123.
92. Parnigotto P P, Bernuzzo S, Bruno P et al. Farmaco 1998: 53: 125-131.
93. Fartasch M, Ponec M. J Invest Dermatol 1994: 102: 366-374.
94. Lee D Y, Ahn H T, Cho K H. J Dermatol Sci 2000: 23: 132-137.
95. Duval C, Schmidt R, Regnier M et al. Exp Dermatol 2003: 12 (Suppl 2): 64-70.
96. Barnes L, Dumas M, Juan M et al. Photochem Photobiol 2010: 86: 933-941.
97. Huang Q, Dawson R, Pegg D et al. Wound Repair Regen 2004: 12: 276-287.
98. Black A F, Bouez C, Perrier E et al. Tissue Eng 2005: 11: 723-733.
99. Gujuluva C N, Baek J H, Shin K H et al. Oncogene 1994: 9: 1819-1827.
100. El-Abaseri T B, Putta S, Hansen L A. Carcinogenesis 2006: 27: 225-231.
101. Zhuang L, Wang B, Sauder D N. J Interferon Cytokine Res 2000: 20: 445-454.
102. Smith M D, Rees J L. J Invest Dermatol 1994: 102: 433-439.
103. Lee J H, An H T, Chung J H et al. Photodermatol Photoimmunol Photomed 2002: 18: 253-261.
104. Bernerd F, Asselineau D. Dev Biol 1997: 183: 123-138.
105. Parenteau N, Bilbo P, Nolte C et al. Cytotechnology 1992: 9: 163-171.
106. Kang J, Chen W, Xia J et al. Int J Mol Med 2008: 21: 777-784.
107. Jean C, Blanc A, Prade-Houdellier N et al. Cancer Res 2009: 69: 3291-3299.
108. Kuhn C, Hurwitz S A, Kumar M G et al. Int J Cancer 1999: 80: 431-438.
109. Suganuma K, Nakajima H, Ohtsuki M et al.J Dermatol Sci 2010: 58: 136-142.
110. Dajee M, Lazarov M, Zhang J Y et al. Nature 2003: 421: 639-643.
111. Lazarov M, Kubo Y, Cai T et al. Nat Med 2002: 8: 1105-1114.
112. Medalie D A, Eming S A, Tompkins R G et al.J Invest Dermatol 1996: 107: 121-127.
113. Choate K A, Medalie D A, Morgan J R et al. Nat Med 1996: 2: 1263-1267.
114. Hachiya A, Sriwiriyanont P, Fujimura T et al. Am J Pathol 2009: 174: 401-413.
115. Halaban R. Pigment Cell Res 2000: 13: 4-14.
116. Czajkowski R. Int J Dermatol 2011: 50: 180-183.
117. Yap A S, Brieher W M, Gumbiner B M. Annu Rev Cell Dev Biol 1997: 13: 119-146.
118. Liu F, Luo X S, Shen H Y et al. Skin Res Technol 2011: doi:.
119. Liu Y, Suwa F, Wang X et al. Cell Biol Int 2007: 31: 985-990.
120. Lee D Y, Lee J H, Lee E S et al. Arch Dermatol Res 2003: 294: 10-11.
121. Nakazawa K, Kalassy M, Sahuc F et al. Med Biol Eng Comput 1998: 36: 813-820.
122. Todd C, Hewitt S D, Kempenaar J et al. Arch Dermatol Res 1993: 285: 455-459.
123. Wang Z, Li X, Yang Z et al. Int J Cosmet Sci 2008: 30: 121-130.
124. Takeyama R, Takekoshi S, Nagata H et al.J Mol Histol 2004: 35: 157-165.
125. Levenberg S, Ferreira L S, Chen-Konak L et al. Nat Protoc 2010: 5: 1115-1126.
126. Antonicelli F, Lorin J, Kurdykowski S et al. Br J Dermatol 2011: 164: 720-728.
127. Matsumura Y, Moodycliffe A M, Nghiem D X et al. Am J Pathol 2004: 165: 879-887.
128. Pines A, Backendorf C, Alekseev S et al. DNA Repair 2009: 8: 153-161.
129. Sand J M, Aziz M H, Dreckschmidt N E et al.J Invest Dermatol 2010: 130: 270-277.
130. De Fabo E C. Prog Biophys Mol Biol 2006: 92: 97-104.
131. Noonan F P, Dudek J, Merlino G et al. Pigment Cell Res 2003: 16: 16-25.
132. Besaratinia A, Pfeifer G P. FASEB J 2010: 24: 2612-2619.
133. Caulin C, Nguyen T, Lang G A et al.J Clin Invest 2007: 117: 1893-1901.
134. Jackson I J, Budd P S, Keighren M et al. Hum Mol Genet 2007: 16: 2341-2348.
135. Acin S, Li Z, Mejia O et al.J Pathol 2011: 225: 479-489.
136. Mancuso M, Gallo D, Leonardi S et al. Carcinogenesis 2008: 30: 340-347.
137. Kowalczyk M C, Kowalczyk P, Tolstykh O et al. Cancer Prev Res (Phila) 2010: 3: 170-178.
138. Lou Y R, Peng Q Y, Li T et al. Carcinogenesis 2011: 32: 1078-1084.
139. Alameda J P, Moreno-Maldonado R, Fernandez-Acenero M J et al. PLoS ONE 2011; 6: e21984.
140. Milling S W, Sai T, Silvers W K et al. Melanoma Res 2004: 14: 555-562.
141. Teichert A E, Elalieh H, Elias P M et al.J Invest Dermatol 2011: 131: 2289-2297.
142. Ikehata H, Okuyama R, Ogawa E et al. mutagen 2010: 25: 397-405.
143. Zhou B, Wu H, Li W et al. Ir J Med Sci 2010: 180: 721-726.